Company: CNCKW
Filing Date: 2025-11-18
Form Type: 424B3
Source: 0001913847-25-000033
Chunk: 41

Company: Coincheck Group N.V.
Filing Date: 2025-11-18
Form: 424B3
Chunk 41
---
2025, a decrease of ¥5 million, or 58%, from ¥9 million for the six months ended September 2024. The financial income of ¥9 million for the six months ended September 2024 was a derivatives gain.

Financial expenses . Financial expenses were ¥187 million for the six months ended September 2025, an increase of ¥162 million, or 671%, from ¥24 million for the six months ended September 2024. The increase was due mainly to change in fair value of warrant liability of ¥109 million for the six months ended September 2025.

Income tax expenses . Income tax expenses were ¥674 million for the six months ended September 2025, an increase of ¥460 million, or 215%, from ¥214 million for the six months ended September 2024. The increase in income tax expenses was due mainly to higher taxable income for the six months ended September 2025.

#### Non-IFRS Financial Measures
In addition to our results determined in accordance with IFRS Accounting Standards, we present EBITDA and Adjusted EBITDA, both non-IFRS measures, because we believe they are useful in evaluating our operating performance.

36

We use EBITDA and Adjusted EBITDA to evaluate our ongoing operations and for internal planning and forecasting purposes. We believe that EBITDA and Adjusted EBITDA may be helpful to investors because they provide consistency and comparability with past financial performance. However, EBITDA and Adjusted EBITDA are presented for supplemental informational purposes only, have limitations as an analytical tool and should not be considered in isolation or as a substitute for our financial information presented in accordance with IFRS Accounting Standards. Please also see “Overview” near the beginning of this discussion and analysis for an explanation of our change in calculating Adjusted EBITDA beginning with the quarter ended June 30, 2025.

A reconciliation is provided below for each non-IFRS financial measure to the most directly comparable financial measure stated in accordance with IFRS Accounting Standards. Investors are encouraged to review the related IFRS financial measures and the reconciliation of these non-IFRS financial measures to their most directly comparable IFRS financial measures, and not to rely on any single financial measure to evaluate our business.

The following tables present reconciliations of our non-IFRS financial measures:

#### Reconciliation of EBITDA to Net Profit
|                                    |     | For the three months ended | September 30, 2025 |